EA200901093A1 - Способ ускорения роста ногтей, основанный на применении хитозана - Google Patents

Способ ускорения роста ногтей, основанный на применении хитозана

Info

Publication number
EA200901093A1
EA200901093A1 EA200901093A EA200901093A EA200901093A1 EA 200901093 A1 EA200901093 A1 EA 200901093A1 EA 200901093 A EA200901093 A EA 200901093A EA 200901093 A EA200901093 A EA 200901093A EA 200901093 A1 EA200901093 A1 EA 200901093A1
Authority
EA
Eurasian Patent Office
Prior art keywords
chitosan
nail
nails
growth
accelerating growth
Prior art date
Application number
EA200901093A
Other languages
English (en)
Other versions
EA018390B1 (ru
Inventor
Федерико Маилланд
Original Assignee
Полихем С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200901093(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Полихем С.А. filed Critical Полихем С.А.
Publication of EA200901093A1 publication Critical patent/EA200901093A1/ru
Publication of EA018390B1 publication Critical patent/EA018390B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Abstract

Данное изобретение относится к применению хитозана, производного хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей. Изобретение, кроме того, относится к применению хитозана для ускорения роста ногтей во время лечения болезней ногтей, дистрофии или других состояний ногтей, чтобы значительно сократить процессы лечения упомянутых болезней ногтей, дистрофии ногтей и других состояний ногтей.
EA200901093A 2007-02-14 2008-02-07 Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей EA018390B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102335A EP1958638A1 (en) 2007-02-14 2007-02-14 Use of chitosans to increase nail growth rate
PCT/EP2008/051477 WO2008098869A2 (en) 2007-02-14 2008-02-07 Use of chitosans to increase nail growth rate

Publications (2)

Publication Number Publication Date
EA200901093A1 true EA200901093A1 (ru) 2010-02-26
EA018390B1 EA018390B1 (ru) 2013-07-30

Family

ID=38345983

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201270116A EA201270116A1 (ru) 2007-02-14 2008-02-07 Применение лекарственной формы для наружного нанесения, содержащей хитозан
EA200901093A EA018390B1 (ru) 2007-02-14 2008-02-07 Применение хитозана, аминополисахарида хитозана и/или его физиологически приемлемой соли для ускорения роста ногтей

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201270116A EA201270116A1 (ru) 2007-02-14 2008-02-07 Применение лекарственной формы для наружного нанесения, содержащей хитозан

Country Status (32)

Country Link
US (3) US8680074B2 (ru)
EP (3) EP1958638A1 (ru)
JP (3) JP5426401B2 (ru)
KR (2) KR101323762B1 (ru)
CN (2) CN102988405A (ru)
AR (1) AR065316A1 (ru)
AT (1) ATE522221T1 (ru)
AU (1) AU2008214693B2 (ru)
BR (1) BRPI0807595A2 (ru)
CA (1) CA2677715C (ru)
CL (2) CL2008000444A1 (ru)
CO (1) CO6230979A2 (ru)
CY (2) CY1112058T1 (ru)
DK (2) DK2377541T3 (ru)
EA (2) EA201270116A1 (ru)
ES (2) ES2436647T3 (ru)
HK (1) HK1133189A1 (ru)
HR (2) HRP20110667T1 (ru)
IL (1) IL200269A (ru)
MA (1) MA31236B1 (ru)
ME (1) ME00830B (ru)
MX (1) MX2009008686A (ru)
MY (2) MY154499A (ru)
NZ (1) NZ578896A (ru)
PH (1) PH12014500274A1 (ru)
PL (2) PL2377541T3 (ru)
PT (2) PT2117564E (ru)
RS (2) RS52031B (ru)
SI (2) SI2377541T1 (ru)
UA (1) UA100011C2 (ru)
WO (1) WO2008098869A2 (ru)
ZA (1) ZA200905443B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
WO2010109423A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
AU2012318823A1 (en) * 2011-10-05 2014-04-24 Allergan, Inc. Compositions for enhancing nail health
ES2718848T3 (es) * 2011-12-20 2019-07-04 Urgo Rech Innovation Et Developpement Composición tópica filmógena y su uso para tratar o prevenir la onicofagia
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (en) * 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropyl chitosan for the treatment of onychomycosis
EP2910245A1 (en) * 2014-02-21 2015-08-26 Polichem SA Topical antifungal composition for treating onychomycosis
CN109893472A (zh) * 2019-04-09 2019-06-18 涿州皓原箔业有限公司 一种环保无毒水性卸甲液及其制备方法
ES2834732B2 (es) * 2019-12-17 2022-03-24 Univ Valladolid Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento
CN111388416B (zh) * 2020-02-26 2022-03-08 浙江康德药业集团股份有限公司 一种盐酸利多卡因胶浆剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
EP0615745B1 (en) 1993-02-19 1997-05-02 Howard Green Compositions containing corneocyte proteins
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
RU2108114C1 (ru) * 1996-12-27 1998-04-10 Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. Биологическая композиция для лечения ран "коллахит"
ITTO980264A1 (it) 1998-03-26 1999-09-26 Silvio Rossi Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
WO2003051376A1 (en) * 2001-12-14 2003-06-26 Ism Biopolymer Inc. Chitosan oligosaccharides and uses thereof
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
JP3881992B2 (ja) 2004-07-30 2007-02-14 シャープ株式会社 受信装置、受信プログラム、および受信プログラムを記録した記録媒体
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
AU2008214693A2 (en) 2009-09-10
JP6045663B2 (ja) 2016-12-14
SI2117564T1 (sl) 2011-12-30
ZA200905443B (en) 2010-10-27
EP2377541A1 (en) 2011-10-19
HRP20131175T1 (hr) 2014-01-17
EP2117564A2 (en) 2009-11-18
ATE522221T1 (de) 2011-09-15
CN101663039A (zh) 2010-03-03
CY1115136T1 (el) 2016-12-14
DK2117564T3 (da) 2011-10-17
US20100152133A1 (en) 2010-06-17
JP2015221823A (ja) 2015-12-10
HRP20110667T1 (hr) 2011-10-31
RS53143B (en) 2014-06-30
CL2008000444A1 (es) 2008-08-22
US20160015620A1 (en) 2016-01-21
JP5426401B2 (ja) 2014-02-26
US9173827B2 (en) 2015-11-03
UA100011C2 (ru) 2012-11-12
DK2377541T3 (da) 2013-11-11
PL2377541T3 (pl) 2014-04-30
ES2436647T3 (es) 2014-01-03
CO6230979A2 (es) 2010-12-20
SI2377541T1 (sl) 2014-01-31
PL2117564T3 (pl) 2012-03-30
HK1133189A1 (en) 2010-03-19
EA018390B1 (ru) 2013-07-30
CN101663039B (zh) 2013-08-07
PT2117564E (pt) 2011-10-17
MA31236B1 (fr) 2010-03-01
AU2008214693B2 (en) 2013-05-02
KR20110075043A (ko) 2011-07-05
EP2117564B1 (en) 2011-08-31
EP1958638A1 (en) 2008-08-20
KR101131015B1 (ko) 2012-03-29
WO2008098869A3 (en) 2008-10-09
MY163297A (en) 2017-09-15
AU2008214693A1 (en) 2008-08-21
JP2013213048A (ja) 2013-10-17
PT2377541E (pt) 2013-11-21
RS52031B (en) 2012-04-30
NZ578896A (en) 2012-02-24
KR101323762B1 (ko) 2013-11-01
EP2377541B1 (en) 2013-10-23
EA201270116A1 (ru) 2012-06-29
JP2010518138A (ja) 2010-05-27
BRPI0807595A2 (pt) 2014-07-22
ES2369116T3 (es) 2011-11-25
CL2013002052A1 (es) 2014-02-21
WO2008098869A2 (en) 2008-08-21
ME00830B (me) 2012-03-20
KR20090121312A (ko) 2009-11-25
CY1112058T1 (el) 2015-11-04
US8680074B2 (en) 2014-03-25
AR065316A1 (es) 2009-05-27
IL200269A (en) 2015-10-29
CA2677715C (en) 2014-10-14
US20140147401A1 (en) 2014-05-29
IL200269A0 (en) 2010-04-29
PH12014500274A1 (en) 2016-06-06
MX2009008686A (es) 2009-08-21
CA2677715A1 (en) 2008-08-21
CN102988405A (zh) 2013-03-27
MY154499A (en) 2015-06-30

Similar Documents

Publication Publication Date Title
EA200901093A1 (ru) Способ ускорения роста ногтей, основанный на применении хитозана
DE602006018961D1 (de) KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZOL, ZUBEREITUNGSVERFAHREN DAFÜR UND DESSEN VERWENDUNG ZUR ARZNEIMITTELHERSTELLUNG
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2006003492A3 (en) Compositions and methods for treating pathological infections
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
WO2007112052A3 (en) Formulations and methods for vascular permeability-related diseases or conditions
WO2008115469A3 (en) Role of hedgehog signaling in atherosclerosis and cardiovascular disease
MX341883B (es) Composicion farmaceutica para el tratamiento y prevencion de canceres.
EP2628486A3 (en) Method for treating bone fracture with anti-sclerostin antibodies
EA201001691A1 (ru) Антитела к гранулоцитарно-макрофагальному колониестимулирующему фактору
WO2009023710A3 (en) Xanthohumol-enriched hop extract
MY159244A (en) Method of reducing intraocular pressure in humans
SE0701244L (sv) Distans för implantat
UA92593C2 (ru) Лечение мастита энрофлоксацином
WO2010036567A3 (en) Harmine compounds for promoting bone growth
WO2010022201A3 (en) Folinic acid derivatives for promoting bone growth
MX370065B (es) Acido (2r,4r)-5-(5'-cloro-2'-fluorobifenil-4-il)-2-hidroxi-4-[(5-m etiloxazol-2-carbonil)amino]pentanoico.
WO2010098583A2 (ko) 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물
MD20140043A2 (ru) Устройство и метод косметической коррекции вросших ногтей пальцев ног
WO2010025135A3 (en) Trimeprazine and ethopropazine derivatives for promoting bone growth
WO2010039920A3 (en) Boldine compounds for promoting bone growth
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
WO2010046865A3 (en) Ophthalmic administration of a composition including brimonidine as a mist
WO2010011599A3 (en) Pimethixene derivatives for promoting bone growth
WO2007021933A3 (en) Methods and compositions for use in treating vascular diseases and conditions

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU